Shopping Cart

Acne Vulgaris Global Clinical Trials Review, H1, 2017

SKU
GDHC4067CTIDB
READ MORE
USD 2,500
Single User License
USD 2,500
Site License
USD 5,000
Corporate User License
USD 7,500

Acne Vulgaris Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, "Acne Vulgaris Global Clinical Trials Review, H1, 2017" provides an overview of Acne Vulgaris clinical trials scenario. This report p

READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Acne Vulgaris Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, "Acne Vulgaris Global Clinical Trials Review, H1, 2017" provides an overview of Acne Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Acne Vulgaris. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

* Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Report Guidance 4

Clinical Trials by Region 5

Clinical Trials and Average Enrollment by Country 6

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8

Top Five Countries Contributing to Clinical Trials in Europe 9

Top Countries Contributing to Clinical Trials in North America 10

Top Countries Contributing to Clinical Trials in Middle East and Africa 11

Top Five Countries Contributing to Clinical Trials in Central and South America 12

Clinical Trials by G7 Countries: Proportion of Acne Vulgaris to Dermatology Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by E7 Countries: Proportion of Acne Vulgaris to Dermatology Clinical Trials 16

Clinical Trials by Phase in E7 Countries 17

Clinical Trials in E7 Countries by Trial Status 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Clinical Trials by End Point Status 22

Subjects Recruited Over a Period of Time 23

Clinical Trials by Sponsor Type 24

Prominent Sponsors 25

Top Companies Participating in Acne Vulgaris Therapeutics Clinical Trials 26

Prominent Drugs 27

Latest Clinical Trials News on Acne Vulgaris 28

Feb 07, 2017: Vyome Announces Top-line Results from Phase 1 Study of VB-1953 for Patients with Facial Acne Vulgaris 28

Jan 27, 2017: Novan Reports Topline Results from SB204 Phase 3 Pivotal Trials 28

Jan 26, 2017: SPIE Photonics West Presentations to Show BioPharmX was First to Visualize Minocycline on the Skin Using Multiphoton Microscopy 29

Jan 12, 2017: BioPharmX Data Suggest Anti-Inflammatory Activity of BPX-01 Topical Minocycline Gel 29

Jan 04, 2017: BioPharmX Completes Enrollment of BPX-01 Phase 2b OPAL Clinical Trial for Acne Vulgaris 30

Jan 03, 2017: Dermira Initiates Phase 3 Clinical Program in Acne 30

Dec 01, 2016: BioPharmX Poster at ASCB Annual Meeting to Show Topical Minocycline Has Potential to Deliver Non-Antibiotic Benefits 31

Nov 28, 2016: Foamix Announces Completion of Patient Enrollment in Phase 3 Acne Trials for Minocycline Foam FMX101 31

Clinical Trial Profile Snapshots 32

Appendix 324

Abbreviations 324

Definitions 324

Research Methodology 325

Secondary Research 325

About GlobalData 326

Contact Us 326

Disclaimer 326

Source 327


List Of Figure

List of Figures

Acne Vulgaris Therapeutics, Global, Clinical Trials by Region (%), 2017* 5

Acne Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6

Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7

Acne Vulgaris Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 8

Acne Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 9

Acne Vulgaris Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 10

Acne Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 11

Acne Vulgaris Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 12

Proportion of Acne Vulgaris to Dermatology Clinical Trials, G7 Countries (%), 2017* 13

Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14

Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15

Proportion of Acne Vulgaris to Dermatology Clinical Trials, E7 Countries (%), 2017* 16

Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17

Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18

Acne Vulgaris Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19

Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20

Acne Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21

Acne Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22

Acne Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23

Acne Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24

Acne Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25

Acne Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26

Acne Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

GlobalData Methodology 325


List Of Table

List of Tables

Acne Vulgaris Therapeutics, Global, Clinical Trials by Region, 2017* 5

Acne Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6

Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7

Acne Vulgaris Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 8

Acne Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 9

Acne Vulgaris Therapeutics Clinical Trials, North America, Top Countries, 2017* 10

Acne Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 11

Acne Vulgaris Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 12

Proportion of Acne Vulgaris to Dermatology Clinical Trials, G7 Countries (%), 2017* 13

Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14

Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15

Proportion of Acne Vulgaris to Dermatology Clinical Trials, E7 Countries (%), 2017* 16

Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17

Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18

Acne Vulgaris Therapeutics, Global, Clinical Trials by Phase, 2017* 19

Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20

Acne Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21

Acne Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22

Acne Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23

Acne Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24

Acne Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25

Acne Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26

Acne Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

To know more information on Purchase by Section, please send a mail to

Companies

Nestle SA, GlaxoSmithKline Plc, Valeant Pharmaceuticals International Inc, Allergan Plc, TKL Research Inc, Sun Pharmaceutical Industries Ltd, DermResearch Inc, Novan Inc, Maruho Co Ltd, Bayer AG

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.